A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 158 participants.
Also called NCT06717360
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 158 participants
- Registry
-
NCT06717360
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT06717360. Randomized; quadruple masking; primary purpose treatment. Start 2024-09-30 (actual); primary completion 2025-07-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- AG2304T
- Intervention (Drug)
- AG2304R
- Lead sponsor
- Ahn-Gook Pharmaceuticals Co.,Ltd
Record details
- Record id
cardio:ct-nct06717360- Content hash
346fcad270a22c9ad928727564935738af6eb71a500e418eb88c0cdcc394d7bc